BridgeBio Pharma: A Rising Star in Biotech with Cautionary Notes
BridgeBio Pharma, a biotech company focused on genetic diseases, has seen a remarkable surge in its stock price, reaching an all-time high of $75. 10. Over the past year, the stock has soared by 145%, catching the attention of both Wall Street and individual investors. The company's market value sta